8-tricycloalkyl xanthine derivatives
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsJunichi Shimada, Takashi Kuwabara, Tohru Yasuzawa, Hiroshi Magara, Hiromi Nonaka, Hideaki Kusaka, Fumio Suzuki
Life of this patent
Estimating the term…
Loading patent…
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsJunichi Shimada, Takashi Kuwabara, Tohru Yasuzawa, Hiroshi Magara, Hiromi Nonaka, Hideaki Kusaka, Fumio Suzuki
Estimating the term…
There is provided a novel xanthine Compound(I) ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and each represent hydroxy-substituted, oxo-substituted or unsubstituted lower alkyl, Y is a single bond or alkylene, and Q is ##STR2## wherein R.sup.3 and R.sup.4 are the same or different and each represent hydrogen or hydroxy, n is 0 or 1; provided that when both of R.sup.3 and R.sup.4 are hydrogen, at least one of R.sup.1 and R.sup.2 is hydroxy-substituted or oxo-substituted lower alkyl; or a pharmaceutically acceptable salt thereof. The xanthine compound has adenosine A.sub.1 receptor antagonizing activity, and thus shows diuretic effect, renal-protecting effect, bronchodilatory effect, cerebral function improving effect and anti-dementia effect.
A xanthine compound represented by the formula (I) ##STR39## wherein R.sup.1 and R.sup.2 are the same or different and each represent hydroxy-substituted, oxo-substituted or unsubstituted lower alkyl, Y is a single bond or alkylene, and Q is ##STR40## (wherein R.sup.3 and R.sup.4 are the same or different and each represent hydrogen or hydroxy, n is 0 or 1, and when both R.sup.3 and R.sup.4 are hydrogen, at least one of R.sup.1 and R.sup.2 is hydroxy-substituted or oxo-substituted lower alkyl), or ##STR41## (wherein n has the same meaning as defined above);
Dependencies are inferred from the claim text.